SCHEMBL23299012

SCHEMBL23299012

Cc1ccc(N)c(Cn2nnc3ccccc32)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNMA1 Q12791 1/20 0.54
▸ SLC9A1 P19634 5/20 0.52
▸ GRM2 Q14416 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ LMNA P02545 1/20 0.51
▸ TP53 P04637 1/20 0.51
▸ HPGD P15428 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ POLB P06746 2/20 0.50
▸ CYP1A2 P05177 1/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ CYP2C19 P33261 1/20 0.49
▸ ATM Q13315 1/20 0.48
▸ RAB9A P51151 2/20 0.48
▸ GAA P10253 2/20 0.48
▸ NPC1 O15118 1/20 0.48
▸ MGAM O43451 1/20 0.48
▸ AMY1A P0DUB6 1/20 0.48
▸ SI P14410 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29839046 0.83 KCNMA1 (0.69) KCNMA1SLC9A1GRM2KMT2AALDH1A1
SCHEMBL3552907 0.82 KCNMA1 (0.67) KCNMA1SLC9A1GRM2KMT2AALDH1A1
SCHEMBL20815428 0.80 KCNMA1 (0.64) KCNMA1SLC9A1GRM2KMT2AALDH1A1
SCHEMBL22000732 0.76 GRM2 (0.75) KCNMA1SLC9A1GRM2LMNARAB9A
SCHEMBL7599503 0.75 SLC9A1 (0.69) SLC9A1GRM2KMT2AALDH1A1LMNA
SCHEMBL23058946 0.75 KCNMA1 (0.50) KCNMA1SLC9A1GRM2KMT2AALDH1A1
SCHEMBL18617433 0.72 ALDH1A1 (0.55) KCNMA1SLC9A1GRM2KMT2AALDH1A1
SCHEMBL27787872 0.72 KCNMA1 (0.53) KCNMA1SLC9A1GRM2KMT2AALDH1A1
SCHEMBL24460754 0.72 GRM2 (0.68) KCNMA1SLC9A1GRM2KMT2AALDH1A1
SCHEMBL20246151 0.71 SLC9A1 (0.54) KCNMA1SLC9A1GRM2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021080997-A1 3-(4-(11H-DIBENZO[B,E][1,4]AZEPIN-6-YL)PIPERAZIN-1-YL)- AND 3-(4-(DIBENZO[B,F][1,4]OXAZEPIN/THIAZEPIN/DIAZEPIN-11-YL)PIPERAZIN-1-YL)-PROPANO IC ACID DERIVATIVES AS H1 AND 5-HT2A-RECEPTOR MODULATORS FOR THE TREATMENT OF SLEEP DISORDERS ALAIRION, INC. (US) 2021-04-29 — — WO disclosed
Send feedback